In the future, cytokines such as vascular-derived endothelial growth factor (VEGF) and platelet-derived endothelial growth factor (PDGF) may be used to promote would healing, according to Dr. Wax. Ongoing research will determine the role for these cytokines in facial and reconstructive surgery. Dr. Wax thinks that we are still five or 10 years away from having them approved for clinical use.
Explore this issue:February 2008
©2008 The Triological Society